No link between breast cancer and meningioma

Results from a large monoinstitutional retrospective analysis

Carmen Criscitiello, Davide Disalvatore, Michele Santangelo, Nicole Rotmensz, Barbara Bazolli, Patrick Maisonneuve, Aron Goldhirsch, Giuseppe Curigliano

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37%. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.

Original languageEnglish
Pages (from-to)215-217
Number of pages3
JournalCancer Epidemiology Biomarkers and Prevention
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Meningioma
Breast Neoplasms
Incidence
Tumor Biomarkers
Population

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

@article{a8ef0b6a8fec44d390894b7eca7edb41,
title = "No link between breast cancer and meningioma: Results from a large monoinstitutional retrospective analysis",
abstract = "Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37{\%}. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.",
author = "Carmen Criscitiello and Davide Disalvatore and Michele Santangelo and Nicole Rotmensz and Barbara Bazolli and Patrick Maisonneuve and Aron Goldhirsch and Giuseppe Curigliano",
year = "2014",
month = "1",
doi = "10.1158/1055-9965.EPI-13-1041",
language = "English",
volume = "23",
pages = "215--217",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - No link between breast cancer and meningioma

T2 - Results from a large monoinstitutional retrospective analysis

AU - Criscitiello, Carmen

AU - Disalvatore, Davide

AU - Santangelo, Michele

AU - Rotmensz, Nicole

AU - Bazolli, Barbara

AU - Maisonneuve, Patrick

AU - Goldhirsch, Aron

AU - Curigliano, Giuseppe

PY - 2014/1

Y1 - 2014/1

N2 - Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37%. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.

AB - Background: The etiology of meningioma is largely unknown, although breast cancer has been suggested to play a role. Methods: A monoinstitutional, retrospective analysis was performed at European Institute of Oncology on 12,330 patients with breast cancer. The cumulative incidence of meningioma was estimated using the Kaplan-Meier method and the log-rank test was used to assess differences between groups. Results: In total, 33 patients with meningioma were identified from a study population of 12,330, with a 10-year cumulative incidence of meningioma of 0.37%. We did not find a significantly increased risk of meningioma among patients with breast cancer or an association between the hormonal receptor status and the risk of meningioma (P = 0.65). Conclusions: Our results do not support a role of breast cancer or endocrine treatments in meningioma development. Impact: This analysis adds new information on a debated topic. Cancer Epidemiol Biomarkers Prev; 23(1); 215-7.

UR - http://www.scopus.com/inward/record.url?scp=84892770496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892770496&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-13-1041

DO - 10.1158/1055-9965.EPI-13-1041

M3 - Article

VL - 23

SP - 215

EP - 217

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -